Dr
Victoria
Bruce

Trainee Patent Attorney

Glasgow Office

Electronics

Telephone. +44(0) 141 229 5800
Email. [email protected]
Vcard
Linkedin

Experience

Victoria joined HGF in 2016 from academia where she had been working as a post-doctoral researcher within several international collaborations for three years, having previously obtained a PhD in Astrophysics in 2013. Victoria's research involved developing new methods of image analysis and model fitting to characterize the properties of galaxies far back in cosmic time and interpreting these results within the current framework of galaxy formation simulations. She was also previously involved with research into the detectability of extra-solar planets from transit observations during her undergraduate Masters project.

Since joining HGF, Victoria has gained experience drafting and prosecuting patent applications in various fields including telecommunications, power management, medical devices, artificial intelligence and autonomous vehicles.

Specialisms

Industries

Services

Qualifications

Trainee

MPHYS

Astrophysics, First Class, University of St Andrews, 2009

PHD

Astrophysics, University of Edinburgh, 2013

POSTGRADUATE DIPLOMA OR CERTIFICATE

Intellectual Property Law, Bournemouth University, 2017

Related News

Artificial intelligence inventions in healthcare – can you patent them in Europe?

Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …

Read article

Patenting digital mental health

Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder [1]. …

Read article

Patenting antibodies in the US and Europe

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …

Read article

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 10th May 2022

HGF UPC events in Germany and Austria 2022

HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …

Event details
Event - 23rd March 2022

HGF webinar: Getting your first filing right

HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …

Event details
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us